Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PCG Molecular logo — COVID-19 Testing & Vaccines | 2020 to 2023.

PCG Molecular

COVID-19 Testing & Vaccines | 2020 to 2023.

Founded 2016 United States Atlanta, United States 9 employees Biotechnology, Health Care

General Information

Company Name PCG Molecular
Founded Year 2016
Location United States Atlanta, United States +2
Employees 9
Industries Biotechnology, Health Care
Social

Get notified when PCG Molecular moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PCG Molecular

PCG Molecular is a pioneering preventive care diagnostic company founded in 2016. They are dedicated to changing national figures concerning disease and survival rates. Specializing in biotechnology and health care, the company focuses on the research and development of genetic and molecular screens. These screens are designed to detect health problems at an early stage, with an emphasis on ease of administration. Additionally, PCG Molecular offers flexible business models that provide incentives for practitioners to embrace change. Currently, there is no publicly available information about the last investment or the involved investors. The company's slogan, "PCG Molecular is dedicated to the research and development of genetic, molecular screens that detect problems early," effectively captures their mission and vision.

Taxonomy: Genetic testing, Preventive care diagnostics, Molecular screens, Infectious disease testing, Cancer molecular testing, DNA testing, Health insurance coverage, Non-invasive testing, Business model innovation

No funding data available for PCG Molecular yet.

Get notified when PCG Molecular raises funding

PCG Molecular Alternatives & Competitors

PCG Molecular vs
Aura Genetics
Aura Genetics United States

Molecular diagnostics reference laboratory

3 employees
Health Care
PCG Molecular vs
Genomed
Genomed Turkey

Research firm specializes in molecular diagnosis.

Digital Health, Health Care
PCG Molecular vs
G2M | Next Generation IVD solutions for Genomics
G2M | Next Generation IVD solutions for Genomics India

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions.

103 employees
Biotechnology, Health Care

FAQ About PCG Molecular

COVID-19 Testing & Vaccines | 2020 to 2023.
PCG Molecular was founded in 2016.
PCG Molecular is headquartered in Atlanta, United States.
PCG Molecular operates in the following industries: Biotechnology, Health Care.
PCG Molecular has approximately 9 employees.
Top alternatives and competitors to PCG Molecular include Aura Genetics, Genomed, G2M | Next Generation IVD solutions for Genomics, Limay Biosciences, Lite&Fog. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PCG Molecular and Aura Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PCG Molecular and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes